메뉴 건너뛰기




Volumn 19, Issue 4, 2000, Pages 383-387

Management of otitis media: 2000 and beyond

Author keywords

Antibiotics; Management of otitis media; Vaccines

Indexed keywords

ANTIBIOTIC AGENT; ANTIVIRUS AGENT; BACTERIAL VACCINE; DIPHTHERIA TOXIN; INFLUENZA VACCINE; KETOLIDE; OSELTAMIVIR; PNEUMOCOCCUS VACCINE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RESPIRATORY SYNCYTIAL VIRUS ANTIBODY; RIBAVIRIN; UNCLASSIFIED DRUG; VIRUS VACCINE; ZANAMIVIR;

EID: 0034002743     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-200004000-00034     Document Type: Review
Times cited : (29)

References (19)
  • 1
    • 0343845501 scopus 로고
    • Observations in acute otitis media
    • Richardson JR. Observations in acute otitis media. Ann Otol Rhinol Laryngol 1942;51:804-16.
    • (1942) Ann Otol Rhinol Laryngol , vol.51 , pp. 804-816
    • Richardson, J.R.1
  • 3
    • 0031963393 scopus 로고    scopus 로고
    • Principles of judicious use of antimicrobial agents for pediatric upper respiratory tract infections
    • Dowell SF, ed. Principles of judicious use of antimicrobial agents for pediatric upper respiratory tract infections. Pediatrics 1998;101(Suppl 1):163-84.
    • (1998) Pediatrics , vol.101 , Issue.1 SUPPL. , pp. 163-184
    • Dowell, S.F.1
  • 4
    • 9844220300 scopus 로고    scopus 로고
    • Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenza virus infections
    • Hayden FG, Albert DME, Osterhaus DVM, et al. Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenza virus infections. N Engl J Med 1997;337: 874-80.
    • (1997) N Engl J Med , vol.337 , pp. 874-880
    • Hayden, F.G.1    Albert, D.M.E.2    Osterhaus, D.V.M.3
  • 5
    • 0033495482 scopus 로고    scopus 로고
    • Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenza A and B virus infections
    • Monto AS, Fleming DM, Henry D, et al. Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenza A and B virus infections. J Infect Dis 1999;180: 254-61.
    • (1999) J Infect Dis , vol.180 , pp. 254-261
    • Monto, A.S.1    Fleming, D.M.2    Henry, D.3
  • 6
    • 0032696188 scopus 로고    scopus 로고
    • Use of the selective oral neuraminidase inhibitor oseltamivir to prevent influenza
    • Hayden FG, Atmar RL, Schilling M, et al. Use of the selective oral neuraminidase inhibitor oseltamivir to prevent influenza. N Engl J Med 1999;341:1336-43.
    • (1999) N Engl J Med , vol.341 , pp. 1336-1343
    • Hayden, F.G.1    Atmar, R.L.2    Schilling, M.3
  • 7
    • 0021141094 scopus 로고
    • Detection of middle ear effusion by acoustic reflectometry
    • Teele DW, Teele J. Detection of middle ear effusion by acoustic reflectometry. J Pediatr 1984;104:832-8.
    • (1984) J Pediatr , vol.104 , pp. 832-838
    • Teele, D.W.1    Teele, J.2
  • 8
    • 0031806768 scopus 로고    scopus 로고
    • Comparison of spectral gradient acoustic reflectometry and other diagnostic techniques for detection of middle ear effusion in children with middle ear disease
    • Barnett ED, Klein JO, Hawkins KA, et al. Comparison of spectral gradient acoustic reflectometry and other diagnostic techniques for detection of middle ear effusion in children with middle ear disease. Pediatr Infect Dis J 1998;17(Suppl 6):556-9.
    • (1998) Pediatr Infect Dis J , vol.17 , Issue.6 SUPPL. , pp. 556-559
    • Barnett, E.D.1    Klein, J.O.2    Hawkins, K.A.3
  • 9
    • 0033996108 scopus 로고    scopus 로고
    • Efficacy of pneumococcal conjugate vaccines in large scale field trials
    • Shinefield HR, and Black S. Efficacy of pneumococcal conjugate vaccines in large scale field trials. Pediatr Infect Dis J 2000;19: 394-7.
    • (2000) Pediatr Infect Dis J , vol.19 , pp. 394-397
    • Shinefield, H.R.1    Black, S.2
  • 10
    • 0003255194 scopus 로고    scopus 로고
    • Efficacy of a heptavalent pneumococcal conjugate vaccine against serotype-specific, culture-confirmed pneumococcal acute otitis media in infants and children
    • San Francisco, September 26 to 29, 1999. Washington, DC: American Society for Microbiology
    • Eskola J, Kilpi T. Efficacy of a heptavalent pneumococcal conjugate vaccine against serotype-specific, culture-confirmed pneumococcal acute otitis media in infants and children [Addendum]. In: 39th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, September 26 to 29, 1999. Washington, DC: American Society for Microbiology, 1999:16.
    • (1999) 39th Interscience Conference on Antimicrobial Agents and Chemotherapy , pp. 16
    • Eskola, J.1    Kilpi, T.2
  • 11
    • 0028883906 scopus 로고
    • Influenza A vaccine decreases the incidence of otitis media in 6 to 30 month-old children in day care
    • Clements DA, Langdon L, Bland C, Walter E. Influenza A vaccine decreases the incidence of otitis media in 6 to 30 month-old children in day care. Arch Pediatr Adolesc Med 1995;149:1113-7.
    • (1995) Arch Pediatr Adolesc Med , vol.149 , pp. 1113-1117
    • Clements, D.A.1    Langdon, L.2    Bland, C.3    Walter, E.4
  • 12
    • 0032516267 scopus 로고    scopus 로고
    • The efficacy of live attenuated, cold-adapted, trivalent intranasal influenza virus vaccine in children
    • Belshe RB, Mendelman PM, Treanor J, et al. The efficacy of live attenuated, cold-adapted, trivalent intranasal influenza virus vaccine in children. N Engl J Med 1998;338:1459-61.
    • (1998) N Engl J Med , vol.338 , pp. 1459-1461
    • Belshe, R.B.1    Mendelman, P.M.2    Treanor, J.3
  • 13
    • 0030378226 scopus 로고    scopus 로고
    • Respiratory syncytial virus-enriched globulin for the prevention of acute otitis media in high risk children
    • Simoes EA, Groothuis JR, Tristram DA, et al. Respiratory syncytial virus-enriched globulin for the prevention of acute otitis media in high risk children. J Pediatr 1996;129:214-9.
    • (1996) J Pediatr , vol.129 , pp. 214-219
    • Simoes, E.A.1    Groothuis, J.R.2    Tristram, D.A.3
  • 14
    • 0031683919 scopus 로고    scopus 로고
    • Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants
    • The IMPACT-RSV Study Group. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. Pediatrics 1998;102:531-7.
    • (1998) Pediatrics , vol.102 , pp. 531-537
  • 15
    • 0033030916 scopus 로고    scopus 로고
    • Parents, physicians and antibiotic use
    • Bauchner H, Pelton SI, Hein JO. Parents, physicians and antibiotic use. Pediatrics 1999;103:395-401.
    • (1999) Pediatrics , vol.103 , pp. 395-401
    • Bauchner, H.1    Pelton, S.I.2    Hein, J.O.3
  • 16
    • 0029881352 scopus 로고    scopus 로고
    • Oligosaccharide anti-infective agents
    • Zopf D, Roth S. Oligosaccharide anti-infective agents. Lancet 1996;347:1017-21.
    • (1996) Lancet , vol.347 , pp. 1017-1021
    • Zopf, D.1    Roth, S.2
  • 17
    • 0029797851 scopus 로고    scopus 로고
    • Xylitol chewing gum in prevention of acute otitis media: Double blind randomized trial
    • Uhari M, Kontiokari T, Koskela M, Niemela M. Xylitol chewing gum in prevention of acute otitis media: double blind randomized trial. Br Med J 1996;313:1180-4.
    • (1996) Br Med J , vol.313 , pp. 1180-1184
    • Uhari, M.1    Kontiokari, T.2    Koskela, M.3    Niemela, M.4
  • 18
    • 0031658911 scopus 로고    scopus 로고
    • A novel use of xylitol sugar in preventing acute otitis media
    • Uhari M, Kontiokari T, Niemela M. A novel use of xylitol sugar in preventing acute otitis media. Pediatrics 1998;102: 879-84.
    • (1998) Pediatrics , vol.102 , pp. 879-884
    • Uhari, M.1    Kontiokari, T.2    Niemela, M.3
  • 19
    • 0002273713 scopus 로고    scopus 로고
    • Seven herbs every pediatrician should know
    • Kemper KJ. Seven herbs every pediatrician should know. Contemp Pediatr 1996;13:79-93.
    • (1996) Contemp Pediatr , vol.13 , pp. 79-93
    • Kemper, K.J.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.